Caroline Fox

Dr. Caroline Fox is currently Global Development Lead in the Internal Medicine Research Unit at Pfizer. There, she leads early development clinical trials in areas including weight loss, optimal aging, and other cardiometabolic diseases. Her background includes extensive experience in biopharmaceutical leadership roles, including positions as Senior Vice President at Vertex Pharmaceuticals and Quotient Therapeutics, and Vice President at Merck Research Labs, where she served as Head of the Genetics and Pharmacogenomics group. Caroline is also Associate Clinical Professor of Medicine at the Brigham and Women’s Hospital and Harvard Medical School.

Prior to joining the biopharmaceutical industry, she served as Deputy Branch Chief and Principal Investigator at the National Heart, Lung, and Blood (NHLBI) Institute Division of Intramural Research and the Center for Population Studies. Caroline is the author of more than 400 original peer reviewed papers. She was named Thomson Reuters “World’s Most Influential Scientific Minds” from 2014-2020, ranked among the top 20 female scientists worldwide, and is an inducted member into the American Society for Clinical Investigators, an honor society for physician scientists.

Caroline completed her BA and MPH from the University of Michigan, her MD from the University of Pennsylvania, and Internal Medicine residency and Endocrinology fellowship at the Brigham and Women’s Hospital and Harvard Medical School. Caroline is board certified in Endocrinology, and has served as Attending Physician in diabetes and weight management at the BWH for more than 15 years.

Caroline became a mental health advocate after her own acute mental health crisis in December of 2021. While her condition spiraled precipitously, she was not able to seek timely and quality psychiatric care. During the acute course of her illness, which lasted one year and resulted in the loss of her job, she was shocked to find a broken mental health system, even though she herself trained and worked in this system for more than 25 years. Now, she partners with organizations around the United States focusing on improving access to mental health services, helping to reduce the stigma of mental health disorders, and working to better understand the underlying biology of disease in order to develop better treatments.